21 May 2015

NICE, Level 1, City Tower, Piccadilly Plaza, Manchester

The meeting will start promptly at 10:00 and is expected to finish at approximately 15.45

Please note that this agenda is subject to change prior to the meeting.

Final Agenda

1. Welcome and introduction to format of meeting

2. Apologies

3. Any other business

4. Minutes from the last Committee meeting held on 21 April 2015.

5. Appraisal of Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, abatacept and tocilizumab for the treatment of rheumatoid arthritis (review of TA guidance 130, 186, 224, 234 and part review of TA guidance 225 and 247) [ID537]

5.1. Declarations of interest - Part 1 only (open session)

5.2. Introduction by the Chair, Professor Andrew Stevens - Part 1 only (open session)

5.3. Presentation by the Chair, Professor Andrew Stevens - Part 1 and Part 2 (open and closed session)

5.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

6. Appraisal of Idelalisib for previously treated chronic lymphocytic leukaemia [ID764]

6.1. Declarations of interest - Part 1 only (open session)

6.2. Introduction by the Chair, Professor Andrew Stevens - Part 1 only (open session)

6.3. Presentation by the Lead Team - Part 1 and Part 2 (open and closed session)

6.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

 Date, time and venue of next meeting

 Tuesday 21 July 2015, 10:00am, NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BT.

Please note all timings are approximate.

To print this agenda, please right click and select ‘Print’ from the menu

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration is Thursday 07 May 2015. Please note that it may not be possible to accept late registration requests.

Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Sandra.robinson@nice.org.uk

 

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk   

Further information about conducting research is also available in our Common Questions and Answers about meetings in public document.

 

Registration period: 22 April 2015 to 07 May 2015
Registration is closed.